CATALENT MTI PHARMA SOLUTIONS LIMITED

1. CATALENT MTI PHARMA SOLUTIONS LIMITED 2015-07-01 → present
2. MTI PHARMA SOLUTIONS LTD 2012-12-20 → 2015-07-01

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Grant Thornton UK LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Directors have assessed the going concern of the legal entity through to 30 June 2026. The company has limited activity and has limited cash flows outside of the Catalent Inc ("Catalent") group. It is in a net current liabilities position as of 30 June 2024 and is therefore reliant on the support of Catalent to satisfy the going concern assumption. The company has received a support letter from Catalent Inc which confirms that Catalent Inc will assist the company in meeting its liabilities as and when they fall due, but only to the extent that money is not otherwise available to it to meet such liabilities, and has confirmed that it has the ability to provide such support throughout the going concern period to 30 June 2026. Having assessed the responses of the management of Catalent Inc, to their enquiries, the directors have no reason to believe that a material uncertainty exists that may cast significant doubt on the ability of the Catalent group to continue as a going concern and therefore to continue to provide support to the entity as and when it is required.”

Group structure

1. CATALENT MTI PHARMA SOLUTIONS LIMITED · parent
   1. Catalent Micron Technologies Limited 100% · England · provision of contract particle size reduction services to the pharmaceutical industry

Significant events

• “On 5th February 2024, the ultimate parent, Catalent Inc., announced its merger agreement with Novo Holdings Limited, under which Novo Holdings Limited would acquire Catalent Inc. in an all-cash transaction. The acquisition by Novo Holdings Limited was completed on 18th December 2024 after satisfying customary closing conditions, including approval by Catalent Inc. stockholders and receipt of required regulatory approvals.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

7

last 12 months

Capital events

0

last 24 months

Officers appointed

3

last 12 months

Officers resigned

2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.